AG Rayfield Statement on SCOTUS Decision Preserving Mifepristone Access by Mail
Published Date: May 14, 2026
- Categories
- Lead States
- Action Type Statement
“Today’s U.S. Supreme Court decision in the Louisiana mifepristone case protects something fundamental – the ability of Oregonians to access safe, effective, FDA-approved medication that millions of people have relied on for decades. Without mifepristone, patients face longer delays in care, more invasive procedures, and greater risks to their health. We will continue to do everything in our power to preserve full access to mifepristone and all essential healthcare for every Oregonian.” – AG Rayfield